Despite a heightened focus on the co-infections, first identified in the U.S. in 2020, few states have reported flurona hospitalizations to HHS.
As of Jan. 6, the most recent data available, 12 states and Washington, D.C., reported no patients hospitalized with both flu and COVID-19. Hospitals in another 13 states reported having just one or two patients with co-infections, and 16 hospitals reported three to nine patients. Just nine states reported 10 or more patients hospitalized with co-infections, with Virginia topping the list at 20 hospitalizations.
It’s unclear whether the low numbers reflect a low incidence of flurona hospitalizations nationwide or a shortcoming in reporting. Some emerging studies suggest co-infections of flu and other pathogens, including the virus that causes COVID-19, may be more common than originally thought, according to The Atlantic.tic.
The rise of incidental hospitalizations amid the omicron surge has also complicated reporting for hospitals and clouded insights into national COVID-19 hospitalization trends.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
